TNFSF18 and neoplasm: The role of GITRL in modulating T cell response is unclear, but most studies support that GITRL promotes the immune response and enhances tumor rejection [11, 13, 14]; however, GITR exerts anti-inflammatory effects and decreases the autoimmune response [12].